Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn ...
Barchart on MSN
Zimmer Biomet Earnings Preview: What to Expect
With a market cap of $18.8 billion, Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company that designs, ...
StockStory.org on MSN
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead
Over the past six months, Zimmer Biomet’s stock price fell to $99.17. Shareholders have lost 12% of their capital, which is disappointing considering the S&P 500 has climbed by 24.7%. This might have ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ("Zimmer Biomet"), a global medical technology leader, today announced it has completed the acquisition of Monogram Technologies Inc. ("Monogram"), an ...
Zimmer Biomet completes acquisition of Monogram Technologies to expand orthopedic robotics portfolio
Zimmer Biomet (NYSE: ZBH) + Zimmer Biomet Holdings, Inc. $98.85 1.92% Open 98.935 Day High 101.083 52 Week High 133.6 52 Week ...
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes ...
Investors in Zimmer Biomet Holdings Inc (Symbol: ZBH) saw new options begin trading this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet (ZBH) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better ...
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results